RLMD
#3068
Relmada Therapeutics, Inc. - Common Stock
3.4 0 USD
-0.03%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-3.13%
Variazione Mensile
-24.94%
Variazione di 6 mesi
-54.55%
Variazione Annuale
+71.72%
Chiusura Precedente
3.5 1
Open
3.5 0
Minimo
3.3 7
Massimo
3.5 5
Financials
2017
Current report, 27 Jan 2017
RELMADA THERAPEUTICS, INC. current report, 27 January 2017
8-K
2016
Quarterly report, Q2 FY2017
RELMADA THERAPEUTICS, INC. quarterly report, Q2 FY2017
10-Q
Quarterly report, Q1 FY2017
RELMADA THERAPEUTICS, INC. quarterly report, Q1 FY2017
10-Q
Current report, 06 Sep 2016
RELMADA THERAPEUTICS, INC. current report, 06 September 2016
8-K
Annual report, FY2016
RELMADA THERAPEUTICS, INC. annual report, FY2016
10-K
Current report, 16 Jun 2016
RELMADA THERAPEUTICS, INC. current report, 16 June 2016
8-K
Current report, 11 May 2016
RELMADA THERAPEUTICS, INC. current report, 11 May 2016
8-K
Quarterly report, Q3 FY2016
RELMADA THERAPEUTICS, INC. quarterly report, Q3 FY2016
10-Q
Current report, 13 Jan 2016
RELMADA THERAPEUTICS, INC. current report, 13 January 2016
8-K
2015
Quarterly report, Q2 FY2016
RELMADA THERAPEUTICS, INC. quarterly report, Q2 FY2016
10-Q